Stock surges 7.9% after USFDA approves Benzonatate Capsules 100mg and 200mg, generic of Pfizer's Tessalon; Q3FY26 revenue up ...
Learn how pharma company Pfizer makes money through prescription drugs, vaccines, oncology treatments, and global ...
Shares of Pfizer Inc. PFE advanced 1.12% to $28.08 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.91% to 6,528.52 and ...
Pfizer Inc. shares ticked up modestly Tuesday as investors weighed fresh positive oncology data against the pharmaceutical ...
Pfizer Inc. and Bain Capital Investors LLC must defend against allegations they had power and influence over Cerevel ...
Markets have delivered plenty of twists lately, with inflation cooling but growth uneven and volatility still lurking around ...
Pfizer (PFE) stock is in focus as the company plans to close its South San Francisco research site and office by April. Read ...
Pfizer operates as a global biopharmaceutical leader The company maintains diversified therapeutic and vaccine portfolio Market activity reflects alignment with S&P 500 Fund trends Pfizer Inc.
Johnson & Johnson (JNJ) is rated a Hold: defensive quality, DCF valuation, easing litigation, and dividend outlook—see key ...
When the topic of Lyme disease comes up, Robert F. Kennedy Jr. often tells a story about standing in a bathtub in Westchester ...
US and European stocks rose Tuesday on hopes for a quick end to the Middle East war, while oil prices traded mixed amid the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results